Nasal High Flow Use in COPD Patients with Hypercapnic Respiratory Failure: Treatment Algorithm & Review of the Literature.
COPD
; 17(1): 101-111, 2020 02.
Article
in En
| MEDLINE
| ID: mdl-31965868
ABSTRACT
Nasal high flow (NHF) therapy has recently gained attention as a new respiratory support system and is increasingly being utilized in every day clinical practice. Recent studies suggest that it may also be effective in patients with hypercapnia and suggest NHF as a possible alternative for patients who cannot tolerate standard noninvasive ventilation. The present review discusses the mechanisms of action that make NHF potentially suitable for chronic obstructive pulmonary disease (COPD) patients and evaluates the current evidence of NHF use for treatment of stable hypercapnic COPD patients as well as acute hypercapnic exacerbation of COPD. An algorithm is also proposed for the clinical application of NHF in patients with acute hypercapnic exacerbation of COPD, based on current literature.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oxygen Inhalation Therapy
/
Respiratory Insufficiency
/
Algorithms
/
Pulmonary Disease, Chronic Obstructive
/
Hypercapnia
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
COPD
Year:
2020
Document type:
Article
Affiliation country: